Health Boards
›
Psoriasis In The News
Cellceutix files for new psoriasis drug Prurisol
|
Cellceutix files for new psoriasis drug Prurisol
|
Mon-16-04-2012, 14:47 PM
Cellceutix announced today that it has received a response from the Food and Drug Administration ("FDA") related to its pre-IND submission and meeting request on Prurisol™ (also known as KM-133), the Company's compound in development as a novel treatment for psoriasis. The FDA has confirmed mid-June 2012 for a pre-IND meeting focused on Prurisol™ to offer guidance on the Cellceutix initiatives to advance development of this new drug for treating psoriasis.
|
|
« Next Oldest | Next Newest »
|
| Messages In This Thread |
|
Cellceutix files for new psoriasis drug Prurisol - by Fred - Mon-12-03-2012, 14:11 PM
Update - by Fred - Mon-16-04-2012, 14:47 PM
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Drug survival for methotrexate in psoriasis patients | Fred | 7 | 5,799 |
Fri-21-05-2021, 14:44 PM Last Post: D Foster |
|
|
Otezla effectiveness, safety, and drug survival study | Fred | 0 | 1,614 |
Fri-10-04-2020, 12:27 PM Last Post: Fred |
|
|
Methorexate drug survival rate is low in psoriasis patients | Fred | 14 | 11,473 |
Fri-27-07-2018, 13:32 PM Last Post: Turnedlight |
|
|
FDA accepts new drug application of Jemdel for psoriasis | Fred | 0 | 1,900 |
Wed-14-02-2018, 14:37 PM Last Post: Fred |
|
|
Systemic drug survival rates in psoriasis patients | Fred | 0 | 2,088 |
Wed-23-11-2016, 20:55 PM Last Post: Fred |
